The last ‘SCImago Institutions Ranking’ classified the 3,000 best research institutions in the world. Harvard University tops the ranking, but the Catalan institute, is ranked second in Spain and among the best European research centres. Catalonia, and in particular Barcelona is consolidating its position as a biomedical science centre at international level.
For the first time in the world, a foetus having the spina bifida congenital disorder went through a new intra-uterus surgery technique. A medical team from Barcelona’s Vall d’Hebron Hospital operated on the foetus in its 24th week by placing a biological fabric on the spinal cord, in order to protect it from amniotic liquid and to ease the gap’s closing. The baby is now five months old and doctors are confident she may walk without any problems.
The vaccine MVA-B against HIV gets a 90% immune response in its first test with humans. In addition, after a year, the vaccine proves to still be effective in 85% of the individuals. The vaccine is still a prototype but it shows a promising perspective. Soon it will be tested as well as a therapeutic vaccine, for people already infected with HIV-AIDS. The vaccine has been developed by the Spanish High Council of Scientific Research (CSIC), in collaboration with Barcelona’s Hospital Clínic and by Madrid’s Hospital Gregorio Marañón.
Between 2007 and 2010, Catalan research centres and private companies participated in a total of 1,047 projects funded by the Seventh Framework Programmes for Research and Technological Development of the European Union. In total, Catalan researchers have received 384 million euros from the EU in the last four years, which represents a 73% increase in relation to the previous programme, which ran from mid 2002 to 2006.
The study by the Bellvitge Biomedical Research Institute has managed to demonstrate that a molecule similar to glucose can cause the death of cancerous cells. The research would enable to shortly develop treatments for the alveolar rhabdomyosarcoma.
"This could mean a breakthrough in the fight against cancer," said the head of the study Juan Angel Recio from Barcelona-based Vall d’Hebron Research Institute.
The research results were published on the website of the prestigious journal 'Nature Chemistry' and will appear in the print edition as well. The Universitat de Girona is particularly strong in research related to water. The study opens a new path to develop new technologies to carry out artificial photosynthesis.
Lleida’s unique building receives one of the world’s most prestigious architecture awards. The city’s Mayor, Àngel Ros, is said to be proud and highlighted that 75,000 people have already gone through the cultural and business facility since its opening in 2010. La Llotja, designed by the Dutch firm Mecanoo and the Catalan Labb Arquitectura, can be used as a theatre or a conference centre.
Researchers from the Institute of Biomedical Research of Bellvitge (IBIDELL) have shown how brain areas interact as if the person is resting or active. Networks active when resting should be deactivated when awake, but a dysfunction in this process may be behind some diseases. The study has been published in the journal ‘PLoS ONE’.
The website ‘Xplore Health’ is an educational tool for secondary school students. It aims to improve the understanding of biomedical science, as well as “inspire future researchers”. It is a European Commission project, led by Barcelona Science Park (from the University of Barcelona) and involving research centres and science museums from across the EU.
The factory will increase its output of biological and pharmaceutical products by 40% over 3 years, taking work from closing factories in Europe and the United States. The Catalan plant is specialised in animal health and vaccines for livestock. It was bought in 2009 by the North American pharmaceutical giant, in a small town near Girona.
Researchers from Barcelona’s Hospital Clínic and the University of Oviedo (Asturias) have sequenced Chronic Lymphocytic Leukaemia’s entire genome for the first time. Mutations in four genes have been identified as one of the illness triggers. The study was published last Sunday in the prestigious journal ‘Nature’.
An international study led by a Catalan team of researchers finds that the vaccine is not only effective in women between the ages of 9 and 26 , but in women older than 26. Women up to 45 years old could use this preventative vaccine. The study is published this Wednesday in the ‘British Journal of Cancer’.
The Catalan scientist Jordi Sunyer is developing a research study on how children’s brains are affected by air pollution. The hypothesis is that pollution diminisihes children’s capacities to learn.
The manuscript has been discovered in Dalí and Gala’s castle in Púbol. It reveals the writer dimension of the woman with whom the painter Salvador Dalí was deeply in love.